메뉴 건너뛰기




Volumn 23, Issue 4, 2012, Pages 234-238

Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis

Author keywords

atherosclerosis; endothelial dysfunction; serotonin; sphingosine 1 phosphate; statin

Indexed keywords

GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SEROTONIN; SPHINGOSINE 1 PHOSPHATE;

EID: 84860834915     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328351ab0a     Document Type: Article
Times cited : (23)

References (21)
  • 2
    • 62649123264 scopus 로고    scopus 로고
    • Endothelial function and oxidative stress in cardiovascular diseases
    • Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73:411-418.
    • (2009) Circ J , vol.73 , pp. 411-418
    • Higashi, Y.1    Noma, K.2    Yoshizumi, M.3    Kihara, Y.4
  • 3
    • 34248196019 scopus 로고    scopus 로고
    • Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: The cardiovascular health study
    • DOI 10.1161/CIRCULATIONAHA.106.678276
    • Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mesiated dilation predicts incident cardiovascular events in older adults. Circulation 2007; 155:2390-2397. (Pubitemid 46717961)
    • (2007) Circulation , vol.115 , Issue.18 , pp. 2390-2397
    • Yeboah, J.1    Crouse, J.R.2    Hsu, F.-C.3    Burke, G.L.4    Herrington, D.M.5
  • 4
    • 3142534439 scopus 로고    scopus 로고
    • The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular disease
    • DOI 10.1016/j.lab.2004.03.014, PII S0022214304000915
    • Hara K, Hirowatari Y,Yoshika M, Komiyama Y,Tsuka Y,Takahashi H. The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular disease. J Lab Clin Med 2004; 144:31-37. (Pubitemid 38900806)
    • (2004) Journal of Laboratory and Clinical Medicine , vol.144 , Issue.1 , pp. 31-37
    • Hara, K.1    Hirowatari, Y.2    Yoshika, M.3    Komiyama, Y.4    Tsuka, Y.5    Takahashi, H.6
  • 6
    • 0031615089 scopus 로고    scopus 로고
    • Endothelial dysfunction and vascular disease
    • Vanhoutte PM. Endothelial dysfunction and vascular disease. Verh K Acad Geneeskd Belg 1998; 60:251-266.
    • (1998) Verh K Acad Geneeskd Belg , vol.60 , pp. 251-266
    • Vanhoutte, P.M.1
  • 7
    • 0032748866 scopus 로고    scopus 로고
    • Mechanisms of 5-hydroxytryptamine (2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle
    • Banes A, Florian JA, Watts SW. Mechanisms of 5-hydroxytryptamine (2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther 1999; 291:1179-1187.
    • (1999) J Pharmacol Exp Ther , vol.291 , pp. 1179-1187
    • Banes, A.1    Florian, J.A.2    Watts, S.W.3
  • 8
    • 64849106325 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin
    • Rodríguez C, González-D́iez M, Badimon L, Mart́inez-González J. Sphingosine-1-phosphate: a bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. Thromb Haemost 2009; 101:665-673.
    • (2009) Thromb Haemost , vol.101 , pp. 665-673
    • Rodríguez, C.1    González-D́iez, M.2    Badimon, L.3    Mart́inez-González, J.4
  • 9
    • 33644916646 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate in vascular biology: Possible therapeutic strategies to control vascular diseases
    • Yatomi Y. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. Curr Pharm Des 2006; 12:575-587.
    • (2006) Curr Pharm des , vol.12 , pp. 575-587
    • Yatomi, Y.1
  • 11
    • 67449152428 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate and modulation of vascular tone
    • Igarashi J, Michel T. Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res 2009; 82:212-220.
    • (2009) Cardiovasc Res , vol.82 , pp. 212-220
    • Igarashi, J.1    Michel, T.2
  • 12
    • 33847163631 scopus 로고    scopus 로고
    • 1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins
    • DOI 10.1038/sj.bjp.0707114, PII 0707114
    • Igarashi J, Miyoshi M, Hashimoto T, Kubota Y, Kosaka H. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. Br J Pharmacol 2007; 150:470-479. (Pubitemid 46280654)
    • (2007) British Journal of Pharmacology , vol.150 , Issue.4 , pp. 470-479
    • Igarashi, J.1    Miyoshi, M.2    Hashimoto, T.3    Kubota, Y.4    Kosaka, H.5
  • 13
    • 0037162038 scopus 로고    scopus 로고
    • Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: Is this an atherogenic mediator or an anti-atherogenic mediator?
    • DOI 10.1016/S1388-1981(02)00147-6, PII S1388198102001476
    • Okajima F. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 2002; 1582:132-137. (Pubitemid 34634121)
    • (2002) Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids , vol.1582 , Issue.1-3 , pp. 132-137
    • Okajima, F.1
  • 14
    • 38449111826 scopus 로고    scopus 로고
    • Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese
    • Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis
    • Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, et al.; Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14:155-158.
    • (2007) J Atheroscler Thromb , vol.14 , pp. 155-158
    • Teramoto, T.1    Sasaki, J.2    Ueshima, H.3    Egusa, G.4    Kinoshita, M.5    Shimamoto, K.6
  • 15
    • 77952304034 scopus 로고    scopus 로고
    • The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
    • Japanese Society of Hypertension Committee
    • Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al.; Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32:3-107.
    • (2009) Hypertens Res , vol.32 , pp. 3-107
    • Ogihara, T.1    Kikuchi, K.2    Matsuoka, H.3    Fujita, T.4    Higaki, J.5    Horiuchi, M.6
  • 16
    • 1242269943 scopus 로고    scopus 로고
    • High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma
    • DOI 10.1016/j.clinbiochem.2003.11.009
    • Hirowatari Y, Hara K, Kamihata H, Iwasaka T, Takahashi H. High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. Clin Biochem 2004; 37:191-197. (Pubitemid 38221566)
    • (2004) Clinical Biochemistry , vol.37 , Issue.3 , pp. 191-197
    • Hirowatari, Y.1    Hara, K.2    Kamihata, H.3    Iwasaka, T.4    Takahashi, H.5
  • 17
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
    • Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedwald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 20
    • 0034737948 scopus 로고    scopus 로고
    • Protective effect of high density lipoprotein on endothelium-dependent vasodilatation
    • DOI 10.1016/S0167-5273(00)00221-7, PII S0167527300002217
    • Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC. Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol 2000; 73:231-236. (Pubitemid 30332325)
    • (2000) International Journal of Cardiology , vol.73 , Issue.3 , pp. 231-236
    • Li, X.-P.1    Zhao, S.-P.2    Zhang, X.-Y.3    Liu, L.4    Gao, M.5    Zhou, Q.-C.6
  • 21
    • 84860834709 scopus 로고    scopus 로고
    • Possible association between non-invasive parameter of flow-mediated dilatation in brachial artery and whole coronary plaque vulnerability in patients with coronary artery disease
    • [Epub ahead of print]
    • Sawada T, Emoto T, Motoji Y, Hashimoto M, Kageyama H, Terashita D, et al. Possible association between non-invasive parameter of flow-mediated dilatation in brachial artery and whole coronary plaque vulnerability in patients with coronary artery disease. Int J Cardiol 2011 [Epub ahead of print].
    • (2011) Int J Cardiol
    • Sawada, T.1    Emoto, T.2    Motoji, Y.3    Hashimoto, M.4    Kageyama, H.5    Terashita, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.